Naidoo V, Naidoo M, Ghai M. Cell-and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus. Scand J Immunol. 2018;88(6): e12723.

Article  PubMed  Google Scholar 

Ramos-Lopez O, Milagro FI, Riezu-Boj JI, Martinez JA. Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition. Inflamm Res. 2021;70:29–49.

Article  PubMed  CAS  Google Scholar 

Suárez R, Chapela SP, Álvarez-Córdova L, et al. Epigenetics in obesity and diabetes mellitus: new insights. Nutrients. 2023;15(4):811.

Article  PubMed  PubMed Central  Google Scholar 

Arpón A, Milagro FI, Santos JL, García-Granero M, Riezu-Boj J-I, Martínez JA. Interaction among sex, aging, and epigenetic processes concerning visceral fat, insulin resistance, and dyslipidaemia. Front Endocrinol. 2019;10:496.

Article  Google Scholar 

Chambers JC, Loh M, Lehne B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3(7):526–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Muzurović E, Dragnic S, Medenica S, Smolovic B, Bulajic P, Mikhailidis DP. Weight-centric pharmacological management of type 2 diabetes mellitus - an essential component of cardiovascular disease prevention. J Diabetes Complications. 2020;34(8): 107619.

Article  PubMed  Google Scholar 

Sarma S, Sockalingam S, Dash S. Obesity as a multisystem disease: trends in obesity rates and obesity-related complications. Diabetes Obes Metab. 2021;23(Suppl 1):3–16.

Article  PubMed  CAS  Google Scholar 

Czech MP. Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Mol Metab. 2020;34:27–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094–101.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kusminski CM, Scherer PE. Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab. 2012;23(9):435–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tchkonia T, Thomou T, Zhu Y, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013;17(5):644–56.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–98.

Article  PubMed  Google Scholar 

Bray GA, Jablonski KA, Fujimoto WY, et al. Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr. 2008;87(5):1212–8.

Article  PubMed  CAS  Google Scholar 

Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol. 1997;146(3):214–22.

Article  PubMed  CAS  Google Scholar 

Wensveen FM, Valentić S, Šestan M, Turk Wensveen T, Polić B. The, “Big Bang” in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur J Immunol. 2015;45(9):2446–56.

Article  PubMed  CAS  Google Scholar 

Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology. 2002;123(3):882–932.

Article  PubMed  Google Scholar 

Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635–43.

Article  PubMed  CAS  Google Scholar 

Haffner SM. Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes. Eur Heart J Suppl. 2006;8(suppl_B):B20–5.

Article  Google Scholar 

Muzurović E, Peng CC-H, Belanger MJ, Sanoudou D, Mikhailidis DP, Mantzoros CS. Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors. Hypertension. 2022;79(7):1319–26.

Article  PubMed  Google Scholar 

Ng ACT, Delgado V, Borlaug BA, Bax JJ. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol. 2021;18(4):291–304.

Article  PubMed  Google Scholar 

Blüher M, Ceriello A, Davies M, et al. Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come? Endocrinology. Diabetes Metab. 2022;5(3):e00330.

Google Scholar 

Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes. Life Sci. 2020;241:117152.

Article  PubMed  CAS  Google Scholar 

Wittwer JA, Golden SH, Joseph JJ. Diabetes and CVD risk: special considerations in African Americans related to care. Curr Cardiovasc Risk Rep. 2020;14:1–14.

Article  Google Scholar 

Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids. 2010;45(10):907–14.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Palta P, Huang ES, Kalyani RR, Golden SH, Yeh HC. Hemoglobin A(1c) and mortality in older adults with and without diabetes: results from the National Health and Nutrition Examination Surveys (1988–2011). Diabetes Care. 2017;40(4):453–60.

Article  PubMed  PubMed Central  Google Scholar 

Seidu S, Cos X, Brunton S, et al. 2022 update to the position statement by primary care diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care. Prim Care Diabetes. 2022;16(2):223–44.

Article  PubMed  CAS  Google Scholar 

Khunti K, Seidu S. Therapeutic inertia and the legacy of dysglycemia on the microvascular and macrovascular complications of diabetes. Diabetes Care. 2019;42(3):349–51.

Article  PubMed  Google Scholar 

Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynecol Obstet. 2001;75(2):177–84.

Article  CAS  Google Scholar 

Papamargaritis D, le Roux CW, Holst JJ, Davies MJ. New therapies for obesity. Cardiovasc Res. 2022;119(18):2825–42.

Article  PubMed Central  Google Scholar 

American Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(1):100–10.

le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–409.

Article  PubMed  Google Scholar